The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:6 - Any
Updated:11/3/2018
Start Date:June 2012
End Date:June 2022
Contact:Jan Cameron-Watts, RN
Email:jan.cameronwatts@utsouthwestern.edu
Phone:214-645-0555

Use our guide to learn which trials are right for you!

Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

This study seeks to determine the biologic causes of inflammation in patients with Transverse
Myelitis (TM) Neuromyelitis Optica Spectrum Disorder (NMOSD) and related conditions. While
patients will be treated according to decisions with their treating physician, this study
will collect data and samples from patients prospectively to gain a better understanding of
the disease. We are seeking to understand why some patients respond to medications, while
others do not. We also seek to understand what happens biologically, preceding relapses.
Gathering these data and samples will allow researchers to identify new ways of diagnosing
and treating these diseases. Data and samples will be shared with researchers around the
world to support collaborative efforts to treat these conditions.

This study seeks to determine the biologic causes of inflammation in patients with
Neuromyelitis Optica (NMO), Transverse Myelitis (TM), optic neuritis (ON), related conditions
and healthy controls. While patients will be treated according to decisions with their
treating physician, this study will collect data and samples from patients prospectively to
gain a better understanding of the disease. We are seeking to understand why some patients
respond to medications, while others do not. We also seek to understand what happens
biologically, preceding relapses. Gathering these data and samples will allow researchers to
identify new ways of diagnosing and treating these diseases. Data and samples will be shared
with researchers around the world to support collaborative efforts to treat these conditions.

Patients will agree to share medical records, complete questionnaires and donate samples on a
timed basis.

Inclusion Criteria:

- Age 6 years or greater

- Male or Female

- Patient or Parent (in the case of a minor) able to give informed consent

- For patients 10 to 17, patient able to assent

- Patient diagnosed with NMO, NMOSD, TM or ON

Exclusion Criteria:

- Unable to maintain scheduled visits

- Patient has known HIV or hepatitis C infection
We found this trial at
1
site
1801 Inwood Rd
Dallas, Texas 75390
(214) 645-3300
Principal Investigator: Benjamin M Greenberg, MD, MHS
University of Texas Southwestern Medical Center UT Southwestern is an academic medical center, world-renowned for...
?
mi
from
Dallas, TX
Click here to add this to my saved trials